Applied ML Scientist, Cheminformatics (Staff / Principal)

Sorry, this job was removed at 10:16 p.m. (CST) on Monday, Aug 04, 2025
3 Locations
Remote or Hybrid
Artificial Intelligence • Biotech
The Role
About the Team

Join a world-class team at the forefront of AI and biochemistry.

At Genesis Therapeutics, we’re a tight-knit team of proven deep learning researchers, software engineers, and drug discovery pioneers. Our shared mission is nothing short of revolutionary: to forge the next generation of AI foundation models that will unlock groundbreaking therapies for patients with severe diseases.

We don’t just apply machine learning to biology; we are conducting fundamental research at the intersection of machine learning, physics, and computational chemistry, pushing the boundaries of each field. You will work side-by-side with top multidisciplinary researchers to design and build generative foundation models at scale, having access to ample compute and large-scale simulations.

About the Role

This unique role is for a scientist who is passionate about being a catalyst for applying cutting-edge AI to solve real-world drug discovery challenges. You will be the critical bridge between our long-term research and our experimental drug discovery programs. Your mission is to build, evaluate, monitor, and improve our state-of-the-art models directly into active drug programs, leading the charge on model validation, deployment, and analysis to guide the discovery of new medicines.

You will act as both a translator and a strategist, ensuring our research is aimed at the most critical challenges and that our drug hunters can leverage the full power of our industry-leading AI platform. This role requires a deep understanding of cheminformatics, computational chemistry, and experimental techniques, strong data science skills, and a talent for communicating complex ideas to a diverse, multidisciplinary team.

Positions are available at various levels of seniority: Senior, Staff, and Principal.

You will

  • Work directly with project teams to assess model performance and utility, including applicability to current project needs, and collaborate with ML and engineering teams to resolve issues or add new functionality.
  • Assist experimental colleagues with use and interpretation of model predictions by providing context about model quality and prediction uncertainty.
  • Evaluate model quality by validating predictions against project data and internal or external benchmarks.
  • Curate internal and external datasets for model training and validation (in collaboration with experimental teams).
  • Contribute to design and analysis of experiments on model changes and alternative architectures.

You are

  • A seasoned computational scientist with a proven track record of machine learning based methods to impact small molecule drug discovery projects.
  • A cheminformatics expert, fluent in the language of molecular data with hands-on mastery of tools like RDKit or OpenEye.
  • A scientist who speaks the language of experimental drug discovery, with a strong familiarity with common assay types (biochemical/binding/cell-based assays, in vivo studies, etc.) and CADD workflows (docking, virtual screening, ADME prediction, etc.).
  • A rigorous data scientist, with experience inmodeling and analysis of small molecule datasets and passion for statistical validation, uncertainty quantification, and deriving clear insights from complex, noisy data.
  • A hands-on applied scientist and software engineer with strong coding skills in Python and a deep practical knowledge of the applied ML toolkit (e.g., scikit-learn, PyTorch).
  • An exceptional communicator and collaborator, able to act as the bridge between machine learning researchers and experimental scientists.
  • A curious, problem-oriented mind, excited to dive into the emerging field at the intersection of AI, physics, chemistry, and biology and make foundational contributions and discoveries. 
  • A true team player who thrives in highly collaborative, mission-driven environments where science and engineering are deeply intertwined.
  • Inspired by our culture of intellectual curiosity and the shared belief that breakthroughs happen when diverse perspectives and minds unite.

Nice to have's

  • A PhD in Cheminformatics, Computational Chemistry, Computer Science, or a related field.A track record of publications applying machine learning to drug discovery challenges.
  • Deep expertise in advanced modeling techniques such as graph neural networks, multitask modeling, active learning, or Bayesian optimization.
  • Experience with large-scale data management, including SQL databases and data pipelining tools.
  • Strong opinions on molecule featurization and model validation.

Compensation, Benefits, and Perks

  • Competitive compensation package that includes salary and equity.
  • Comprehensive health benefits: Medical, Dental, and Vision (covered 100% for the employees).
  • 401(k) plan.
  • Open (unlimited) PTO policy.
  • Free lunches and dinners at our offices.
  • Paid family leave (maternity and paternity).
  • Life and long- and short-term disability insurance.

About Genesis Therapeutics

Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Genesis was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. Our team of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and generative AI technologies for molecules.

Our team has created the industry's most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets. 

The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has signed AI-focused platform collaborations with major pharmaceutical companies, including most recently Incyte Corporation (Feb 2025) and Gilead Sciences (Sept 2024).

We raised a $200M series B in August 2023, and have raised over $300M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. 

Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.

Similar Jobs

LogicGate Logo LogicGate

Sr. Revenue Enablement Manager

Cloud • Information Technology • Security • Software
Easy Apply
Remote
United States
202 Employees
100K-130K Annually

Affirm Logo Affirm

Marketplace Monetization Manager

Big Data • Fintech • Mobile • Payments • Financial Services
Easy Apply
Remote
United States
2200 Employees
124K-190K Annually

CrowdStrike Logo CrowdStrike

Front-end Engineer

Cloud • Computer Vision • Information Technology • Sales • Security • Cybersecurity
Remote or Hybrid
38 Locations
10000 Employees
120K-180K Annually

CrowdStrike Logo CrowdStrike

Consultant

Cloud • Computer Vision • Information Technology • Sales • Security • Cybersecurity
Remote or Hybrid
USA
10000 Employees
140K-195K Annually
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Burlingame, CA
58 Employees

What We Do

Genesis Therapeutics is unifying AI and biotech to accelerate and optimize drug discovery.

We pioneer novel deep learning and molecular simulation techniques to accelerate the development of new medicines.

Genesis raised its $52M Series A from top tech + biotech investors, Andreessen Horowitz, Rock Springs, and T. Rowe Price.

Story: https://techcrunch.com/2020/12/02/genesis-therapeutics-raises-52m-a-round-for-its-ai-focused-drug-discovery-mission/

We deploy our technology to accelerate a pipeline of several internal drug programs.

Furthermore, Genesis has announced two significant, multi-target collaborations with Genentech and with Eli Lilly, the latter of which entailed a $20M upfront payment with a $670M total deal size.

Now we are scaling the team and technology to support many more programs in parallel as well as increasingly difficult protein targets.
We currently have a team (genesistherapeutics.ai/company.html#team) of about 35 people, split 50/50 between our ML / software team and our biochem team of veteran drug hunters in our own wetlab space. Our ML + software engineers are top-notch -- many graduates from MIT, UC Berkeley, Stanford. Previously worked at OpenAI, Google, Facebook, MemSQL, Jane Street, Dropbox, etc.

We're recruiting pure ML research scientists + software engineers (no bio or chem experience expected) to further our core AI platform as well as scale our drug pipeline.

Likewise, we have several openings in chemistry and biology to join our team of biotech + pharma veterans who are deploying the Genesis ML platform to discover novel drug candidates.

Please apply on our website, or feel free to reach out via email directly: [email protected]

Similar Companies Hiring

Granted Thumbnail
Mobile • Insurance • Healthtech • Financial Services • Artificial Intelligence
New York, New York
23 Employees
Milestone Systems Thumbnail
Software • Security • Other • Big Data Analytics • Artificial Intelligence • Analytics
Lake Oswego, OR
1500 Employees
Idler Thumbnail
Artificial Intelligence
San Francisco, California
6 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account